Location
United States, North America
Check Size
$1M - $75M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Stephen Squinto is an Executive Partner at Orbimed based in New York. He focuses on investing in Pharmaceuticals and BioTech at Seed and Series A stages. His typical investment range is $1M to $75.0M. Squinto has a verified background in venture capital with Orbimed, where he serves as an executive partner.
Previous investments
Enlaza Therapeutics
100M |2024
iECURE
50M |2021
Gennao Bio
40M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free